{"transactions":[{"id":671440,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:23:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":46460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026."}],"balance_after":46460,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":46460},"source":{"system":"sec-edgar","filing":"0002042910-26-000003","document":"form4-09012026_090904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000204291026000003/form4-09012026_090904.xml","form_type":"4"}},{"id":671439,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Common Stock","published_at":"2026-09-01T21:23:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":23540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction represents a grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027."}],"balance_after":143600,"source":{"system":"sec-edgar","filing":"0002042910-26-000003","document":"form4-09012026_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000204291026000003/form4-09012026_090904.xml","form_type":"4"}},{"id":868935,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:05:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":80472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":80472,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":80472},"source":{"system":"sec-edgar","filing":"0001193125-26-088150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526088150/ownership.xml","form_type":"4"}},{"id":868934,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-03-03T21:05:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":44528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":120060,"source":{"system":"sec-edgar","filing":"0001193125-26-088150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526088150/ownership.xml","form_type":"4"}},{"id":901469,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-18T00:47:08.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":8549,"price":5.06,"value":43257.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75532,"source":{"system":"sec-edgar","filing":"0001193125-26-055494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526055494/ownership.xml","form_type":"4"}},{"id":935603,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-20T23:41:49.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":1581,"price":4.86,"value":7683.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":84081,"source":{"system":"sec-edgar","filing":"0001193125-26-016939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526016939/ownership.xml","form_type":"4"}},{"id":1012146,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-10-29T21:05:55.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":896,"price":6.35,"value":5689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":85662,"source":{"system":"sec-edgar","filing":"0001193125-25-256620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312525256620/ownership.xml","form_type":"4"}},{"id":1064257,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":2319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":2319},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064256,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.16,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":1094},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064255,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":4744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4744},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064254,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.21,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":547},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064253,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2026-10-26","underlying":"Common Stock","underlying_shares":547},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064252,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2026-04-11","underlying":"Common Stock","underlying_shares":1094},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064251,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":2554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.07,"expiration_date":"2025-09-03","underlying":"Common Stock","underlying_shares":2554},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064250,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":7722,"price":6.7,"value":51737.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86558,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064249,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":2319,"price":4.25,"value":9855.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":94280,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064248,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1094,"price":3.16,"value":3457.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":91961,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064247,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":4744,"price":2.74,"value":12998.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":90867,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064246,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":547,"price":5.21,"value":2849.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":86123,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064245,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":547,"price":5.48,"value":2997.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":85576,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064244,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1094,"price":5.48,"value":5995.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":85029,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064243,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":2554,"price":5.07,"value":12948.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":83935,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1171138,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-04-17T00:36:48.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":897,"price":5.49,"value":4924.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":81381,"source":{"system":"sec-edgar","filing":"0000950170-25-054954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025054954/ownership.xml","form_type":"4"}},{"id":1264400,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-19T00:31:01.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":1404,"price":7.75,"value":10881.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82278,"source":{"system":"sec-edgar","filing":"0000950170-25-022654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025022654/ownership.xml","form_type":"4"}},{"id":1285377,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:51:16.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":29760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":29760,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":29760},"source":{"system":"sec-edgar","filing":"0000950170-25-013825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025013825/ownership.xml","form_type":"4"}},{"id":1285376,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-04T22:51:16.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":45240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":83682,"source":{"system":"sec-edgar","filing":"0000950170-25-013825","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025013825/ownership.xml","form_type":"4"}},{"id":1298936,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-01-22T02:09:23.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":1001,"price":7.6715,"value":7679.1715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38442,"source":{"system":"sec-edgar","filing":"0000950170-25-007494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025007494/ownership.xml","form_type":"4"}},{"id":1380168,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-10-30T00:23:34.000Z","date":"2024-10-29","kind":"sale","planned":false,"acquired":false,"shares":553,"price":10.7385,"value":5938.3905,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":39443,"source":{"system":"sec-edgar","filing":"0000950170-24-118475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017024118475/ownership.xml","form_type":"4"}}]}